clinical trial of Pippali Rasayana and Nagaradi Kashaya Ghana Vati combination as an adjuvant treatment with ICMR guided medicines in Covid-19 positive mildly symptomatic cases

Randomized comparative clinical trial to assess the efficacy of Pippali Rasayana and Nagaradi Kashaya Ghana Vati combination as an adjuvant treatment with ICMR directed therapy in Covid-19 positive mildly symptomatic cases

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/10/028230

Enrollment

Registered

2020-10-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Pippali Rasayana Nagradi Kashaya Ghana Vati and ICMR directed therapy : Pippali Rasayana- 2gm O.D. orally Rasayana Kala With Honey- 3gm Ghee- 5gm for 14 days Nagaradi Kashaya Ghana Va

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients with Covid -19 test positive (Confirmed using RT-PCR test) 2 Covid-19 positive patients willing to participate in the study. 3 Patients of either sex having age above 20 yrs. below 70 yrs. 4 Covid-19 positive mildly symptomatic

Exclusion criteria

Exclusion criteria: 1. Covid-19 positive patients having moderate to severe symptoms 2. Requiring immediate Intensive care. 3. Patients having complications of major illness such as Liver/Kidney failure Encephalopathy, Epileptic attacks, Coagulopathies, Neuromuscular diseases, Cancer 4. Uncontrolled DM(HbA1C > 7.5) and its complications 5. Uncontrolled HTN and complications 6. Tuberculosis, Pleural Effusion, collapse of any lobe of Lung Ca Lung, COPD patients with dyspnea SPO2 20, requiring Nebulization frequently 7. Immunocompromised patients 8. Anemic patients having Hb 9. BMI > 40 10. Pregnant and Lactating ladies

Design outcomes

Primary

Measure	Time frame
Covid-19 positive mildly symptomatic patients will turn Covid negative after administration of combination of Pippali Rasayana +Nagaradi Kashaya Ghana Vati along with the ICMR guided treatment Recovery from the symptoms will be early and significant after administration of Pippali Rasayana +Nagaradi Kashaya Ghana Vati in mildly symptomatic Covid 19 positive patients Timepoint: Day 0 Day 14	—

Secondary

Measure	Time frame
relief in associated symptoms if anyTimepoint: Day 0 Day 14	—

Countries

India

Contacts

Public ContactDrYogita Abhijit Jamdade

PDEAs Ayurved Rugnalaya and Sterling Multispeciality Hospital Nigdi Pradhikaran Pune 44

medhamaheshjoshi@gmail.com9881465798

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026